2021
DOI: 10.1053/j.semdp.2020.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Undifferentiated and dedifferentiated neoplasms of the female genital tract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 147 publications
0
6
0
Order By: Relevance
“…We present an LG-ESS with sex cord-like differentiation and a PHF1-JAZF1 fusion with deletions flanking telomeric and centromeric loci neighboring We currently know that many tumors previously categorized as undifferentiated uterine sarcomas represent YWHAE or BCOR HG-ESS, IMT with highgrade features, NTRK sarcomas or SMARCA4 deficient sarcomas, among others (24)(25)(26)(27)(28)(29)(30)(31). Molecular characterization becomes particularly important in tumors that lack the typical morphologic features, such as those within the BCOR spectrum.…”
Section: Discussionmentioning
confidence: 99%
“…We present an LG-ESS with sex cord-like differentiation and a PHF1-JAZF1 fusion with deletions flanking telomeric and centromeric loci neighboring We currently know that many tumors previously categorized as undifferentiated uterine sarcomas represent YWHAE or BCOR HG-ESS, IMT with highgrade features, NTRK sarcomas or SMARCA4 deficient sarcomas, among others (24)(25)(26)(27)(28)(29)(30)(31). Molecular characterization becomes particularly important in tumors that lack the typical morphologic features, such as those within the BCOR spectrum.…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis of dedifferentiated/undifferentiated endometrial carcinomas is dismal since patients often present with advanced-stage disease and response to conventional chemotherapy and radiation is at best minimally effective. 25 However, targeted therapy with immune checkpoint inhibitors may be beneficial in patients whose tumors are MMR deficient or harbor a POLE mutation. 26 In summary, we describe the cytological features of metastatic UEC derived from DEC.…”
Section: Case Presentationmentioning
confidence: 99%
“…Ultimately, undifferentiated uterine sarcoma is a diagnosis we can arrive at after examination of the morphology, immunohistochemistry, and molecular profile does not result in the classification of the tumor into a known category. 1 As the name suggests, the features of the morphology and the immunostaining are defined by their lack of evidence for any cell differentiation. 2 Pathologists should be mindful of the true rarity of the diagnosis, and that rates of undifferentiated uterine sarcoma in the literature may not be truly representative, given the likely inclusion in reported series of other sarcoma subtypes.…”
Section: Dr Cummings: What Are the Pathological And Immunohistochemic...mentioning
confidence: 99%
“…Ultimately, undifferentiated uterine sarcoma is a diagnosis we can arrive at after examination of the morphology, immunohistochemistry, and molecular profile does not result in the classification of the tumor into a known category 1. As the name suggests, the features of the morphology and the immunostaining are defined by their lack of evidence for any cell differentiation 2.…”
Section: Dr Cummings: What Are the Pathological And Immunohistochemic...mentioning
confidence: 99%